MACAMI BIOTECH S.L. is the first company in the world created to bring value to the biotechnology of microalgae in the nutraceutical sector, developing innovative solutions to prevent chronic diseases typical of modern society. In a opaque and saturated supplement market filled with mere ingredients, Macami stands out for its quality and transparency, showing the origin and cultivation method of the microalgae, and offering complete nutraceutical formulas for specific goals, whose ingredients are scientifically backed. In addition, it collaborates with CSIC and CIAL on projects aimed at generating knowledge and transforming it into products accessible to the entire society. With a focus on research, efficacy, safety, and sustainability, Macami aims to integrate its nutraceuticals into the daily routine of any individual to enhance the overall well-being of society.
• General Characteristics
- ACTIVITY: Nutraceutical products based on microalgae.
- LOCATION: MADRID
- DATE OF ESTABLISHMENT: 24/10/2024
- CATEGORY: Nutrition
- CONTACT: info@macamibiotech.com
- WEB: www.macamibiotech.com
• Business Structure
- NUMBER OF EMPLOYEES: 4.
- REVENUE: 1-2 million €.
- GENERAL DESCRIPTION: Marketing of nutraceutical solutions based on microalgae for all types of audiences in a B2C model.
- BUSINESS LINES: Nutraceuticals (cosmaceuticals will arrive in 2026).
- INFRASTRUCTURE: Light business model.
• R&D Activities/Interests
TECHNOLOGICAL OFFER/DEMAND:
- Collaborations for the study of the bioactivity of different species of microalgae in human health.
- Collaborations with European microalgae producers.